iSYS
Interventional Systems (iSYS Medizintechnik GmbH) is a medical device company developing innovative B2B and OEM robotic solutions for minimally invasive surgery and percutaneous interventions. Its mission is to make surgical robotics more accessible, improving patient outcomes while simplifying procedures and reducing costs.
Its flagship product, Micromate™, is the world’s first head-to-toe medical robotics platform empowering clinicians with an affordable and easy-to-use miniature robot cleared for any needle-based intervention using either 2D or 3D image guidance. The small and table-mounted robot allows full-body patient access, even within a gantry. It enables users to plan single or multi-needle interventions without angular limitations, perform automatic or joystick-controlled alignment to the planned trajectory within seconds, and select their preferred instruments and workflows. Thanks to its unique features, Micromate™ promotes consistent and repeatable accuracy while reducing procedural times and radiation exposure for both the user and the patient.
Interventional Systems operates an in-house manufacturing facility, providing substantial control over production, intellectual property, and the supply chain while maintaining ISO 13485 certification and adhering to the highest safety and quality standards.
The company is headquartered in Kitzbühel, Austria, with offices in Austria, Germany, and Portugal.
Role in the project
Interventional Systems leads Work Package 3, focusing on advancing robotic and imaging technologies for image-guided percutaneous tumour ablations using CBCT. Our role centers on developing a new generation of portable, wireless robotic systems with autonomous needle steering, designed to integrate seamlessly into CBCT workflows. We’re also responsible for validating these innovations through lab testing and clinical collaboration, ensuring they meet safety, usability, and performance standards. By enhancing precision, workflow efficiency, and patient communication, our contributions aim to demonstrate the clear clinical and operational advantages of robotic-assisted, CBCT-guided interventions over current standard practices.
Team
Srdjan Milosavljevic
Srdjan Milosavljevic, our Chief Technology Officer, holds a bachelor’s degree in computational engineering and a master’s degree in medical image processing and radiation therapy, with a focus on PACS/DICOM protocols for medical imaging. He is also pursuing his PHD in computer assisted surgery with use of machine learning and surgical navigation. Previously a research assistant at the University Hospital of Innsbruck with a prolific publication track record, Srdjan now leads the development of robotic firmware and planning stations at Interventional Systems, while overseeing various hardware and software projects, including testing and certification for IEC 60601 compliance.
Pedro Costa
Pedro Costa, Chief Strategy Officer, holds a master’s degree in Bioengineering and a postgraduate degree in Health Service Management. Since joining in 2016, Pedro has played a key role in the development of Micromate™. As CSO, he focuses on long-term strategies that drive growth and innovation, while ensuring compliance with regulatory requirements. Has several peer-review publications and inventor of a patent on the surgical space.
Marcia Monteiro
Marcia Monteiro, Chief Operations Officer, has a master’s degree in Industrial Engineering and Management, with expertise in logistics, production management, and supply chain. Her experience spans operations strategy and customer success. At Interventional Systems, Marcia drives cross-functional initiatives in product development and supply chain management, ensuring smooth operational flow.
Pedro Pinto
Pedro Pinto, Head of Development, has a master’s degree in mechanical engineering. Since 2019, Pedro has been a key player in R&D projects, particularly in the development of the company’s robotic systems. His expertise includes design review, material selection, and regulatory compliance, critical to the success of our projects
